EYLEA (aflibercept) Injection – Highlights of Prescribing Information (2014) NA

0

 

Ebook Info

  • Published: 2014
  • Format: PDF
  • File Size: 0.81 MB
  • Authors: NA

Description

Prescribing information for EYLEA (aflibercept) Injection, an intravitreal treatment. It is indicated for Neovascular (Wet) Age-Related Macular Degeneration (AMD) and Macular Edema Following Central Retinal Vein Occlusion (CRVO). Details include recommended dosage (typically 2 mg monthly for CRVO, or an initial monthly phase followed by 2 mg every 8 weeks for AMD), administration procedures, contraindications (e.g., ocular infections, active intraocular inflammation), warnings, and adverse reactions.

Free Download

 

Previous articleOxford Medical Handbook – Index to Emergency Topics (2018) Wallin
Next articleGuidelines for Common Pediatric Renal Diseases (2023) Prof. Dr. Abdel Hameed